Pentoxifylline reduces in vitro renal myofibroblast proliferation and collagen secretion

American Journal of Nephrology

Volumn 20, Issue 1, 2000, Pages 82-88

  Hewitson, Tim D ^a   Martic, Marina ^a   Kelynack, Kristen J ^a   Pedagogos, Eugenia ^a   Becker, Gavin J ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Myofibroblast; Pentoxifylline; Transforming growth factor beta

Indexed keywords

ANTIBIOTIC AGENT; COLLAGEN; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE COURSE; DNA SYNTHESIS; FETAL CALF SERUM; FIBROBLAST; FIBROGENESIS; IMMUNOHISTOCHEMISTRY; INTERSTITIAL NEPHRITIS; KIDNEY CELL; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER;

EID: 0033983976     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000013562     Document Type: Article

References (27)

1. Rennke HG, Anderson S, Brenner BM: The progression of renal disease: Structural and functional correlations; in Tisher CC, Brenner BM (eds): Renal pathology with clinical and functional correlations. Philadelphia, J.B. Lippincott, 1994, pp 116-139.
2. Bohle A, Mackensen-Haen S, Gise HV: Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: A morphometric contribution. Am J Nephrol 1987;7:421-433.
3. Alpers CE, Hudkins KL, Floege J, Johnson RJ: Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury. J Am Soc Nephrol 1994;5:201-210.
4. Hewitson TD, Becker GJ: Interstitial myofibroblasts in IgA glomerulonephritis. Am J Nephrol 1995;15:111-117.
5. Hewitson T, Wu H, Becker G: Interstitial myofibroblasts in experimental renal infection and scarring. Am J Nephrol 1995;15:411-417.
6. 1(III) collagen expression in experimental tubulointerstitial nephritis. Kidney Int 1997;51: 926-931.
7. Hewitson T, Becker G: Myofibroblast involvement in renal interstitial fibrosis. Nephrology 1996;2:229-234.
8. Abboud HE: Cytokine mediators of renal inflammation. Curr Opin Nephrol Hypertens 1994;3:329-333.
9. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 1990;346: 371-374.
10. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi U, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 1992;360: 361-364.
11. Alvarez RJ, Sun MJ, Haverty TP, Iozzo RV, Myersc JC, Neilson EG: Biosynthetic and proliferative characteristics of tubulointerstitial fibroblasts probed with paracrine cytokines. Kidney Int 1992;41:14-23.
12. Knecht A, Fine LG, Kleinman KS: Fibroblasts of the rabbit kidney in culture. II. Paracrine stimulation of papillary fibroblasts by PDGF. Am J Physiol 1991;261:F292-F299.
13. Ong ACM, Fine LG: Tubular-derived growth factors and cytokines in the pathogenesis of tubulointerstitial fibrosis: Implications for human renal disease progression. Am J Kidney Dis 1994;23:205-209.
14. Windmeier C, Gressner AM: Pharmacological aspects of pentoxifylline and emphasis on its inhibitory actions on hepatic fibrogenesis. Gen Pharmac 1997;29:181-196.
15. Tsai T-J, Lin R-H, Chang C-C, Chen Y-M, Chen C-F, Ko F-N, Teng C-M: Vasodilator agents modulate rat glomerular mesangial cell growth and collagen synthesis. Nephron 1995; 70:91-99.
16. Preaux AM, Mallat A, Rosenbaun J, Zafrani ES, Mavier P: Pentoxifylline inhibits growth and collagen synthesis of cultured human hepatic myofibroblast-like cells. Hepatology 1997;26:315-322.
17. Isbrucker RA, Peterson TC: Platelet derived growth factor and pentoxifylline modulation of collagen synthesis in myofibroblasts. Tox Appl Pharm 1998;149:120-126.
18. Blazejewski S, Preaux A-M. Mallat A, Brocheriou I, Mavier P, Dhumeaux D, Hartmann D, Schuppan D, Rosenbaum J: Human myofibroblastlike cells obtained by outgrowth are representative of the fibrogenic cells in the liver. Hepatology 1995;22:788-797.
19. Barnes JL, Hastings RR, De La Garza MA: Sequential expression of cellular fibronectin by platelets, macrophages, and mesangial cells in proliferative glomerulonephritis. Am J Pathol 1994;145:585-597.
20. Nakatsukasa H, Nagy P, Evarts RP, Hsia C-C, Marsden E, Thorgeirsson SS: Cellular distribution of transforming growth factor β1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest 1990;85:1833-1843.
21. Hewitson TD, Darby IA, Bisucci T, Jones CL, Becker GJ: Evolution of tubulointerstitial fibrosis in experimental renal infection and scarring. J Am Soc Nephrol 1998;9:632-642.
22. Fullerton MJ, Funder JW: Aldosterone and cardiac fibrosis: in vitro studies. Cardiovasc Res 1994;28:1863-1867.
23. Kreisberg JI, Karnovsky MJ: Glomerular cells in culture. Kidney Int 1983;23:439-447.
24. Lewis MP, Fine LG, Norman JT: Pexicrine effects of basement membrane components on paracrine signaling by renal tubular cells. Kidney Int 1996;49:48-58.
25. Hill PA, Gunning P: Beta and gamma actin mRNAs are differentially located within myoblasts. J Cell Biol 1998;122:825-832.
26. Romanelli RG, Caligiuri A, Carloni V, DeFranco R, Montalto P, Ceni E, Casini A, Gentilini P, Pinzani M: Effect of pentoxifylline on the degradation of procollagen type I produced by human hepatic stellate cells in response to transforming growth factor-β1. Br J Pharmacol 1997;122:1047-1054.
27. Peterson TC: Pentoxifylline prevents fibrosis in an animal model and inhibits platelet-derived growth factor-driven proliferation of fibroblasts. Hepatology 1993;17:486-493.